How many institutions held TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in Q1 2017?

90 institutional investors reported TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value for Q1 2017. Use the holders table for investor-level position and value details.

Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

Q: What does CUSIP G8807B106 represent in this 13F holders report?

CUSIP G8807B106 is the security identifier for TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value used to aggregate holder disclosures.

CUSIP: G8807B106

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class: Equity / Ordinary Share $0.00001 Par Value
Shares outstanding: 51,428,000
Total 13F shares: 45,113,403
Share change: +4,446,910
Total reported value: $1,660,949,113
Put/Call ratio: 126%
Price per share: $36.82
Number of holders: 90
Value change: +$168,197,871
Number of buys: 41
Number of sells: 40

Quarterly Holders Quick Answers

What is CUSIP G8807B106?
CUSIP G8807B106 identifies TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2017
Previous quarter: Q4 2016

Recent filing periods for CUSIP G8807B106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Woodford Investment Management Ltd	13F	Company	20%	10,507,608	$334,983,000	—	31 Dec 2016	13F
BAUPOST GROUP LLC/MA	13F	Company	18%	9,273,991	$295,655,000	—	31 Dec 2016	13F
FMR LLC	13F	Company	11%	5,567,636	$177,496,000	—	31 Dec 2016	13F
VANGUARD GROUP INC	13F	Company	5.7%	2,955,073	$94,208,000	—	31 Dec 2016	13F
BlackRock Fund Advisors	13F	Company	4.3%	2,221,302	$70,815,000	—	31 Dec 2016	13F
FIRST MANHATTAN CO. LLC.	13F	Company	3.6%	1,841,455	$58,705,000	—	31 Dec 2016	13F
Cormorant Asset Management, LP	13F	Company	2.8%	1,425,000	$45,429,000	—	31 Dec 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	2%	1,026,199	$32,715,000	—	31 Dec 2016	13F
NORGES BANK	13F	Company	1.7%	866,724	$27,631,000	—	31 Dec 2016	13F
STATE STREET CORP	13F	Company	1.7%	851,024	$27,136,000	—	31 Dec 2016	13F
Rock Springs Capital Management LP	13F	Company	1.2%	600,000	$19,128,000	—	31 Dec 2016	13F
Foundation Asset Management, LP	13F	Company	0.99%	509,083	$16,230,000	—	31 Dec 2016	13F
NORTHERN TRUST CORP	13F	Company	0.92%	473,554	$15,097,000	—	31 Dec 2016	13F
MARSHALL WACE, LLP	13F	Company	0.8%	408,880	$13,035,000	—	31 Dec 2016	13F
FRANKLIN RESOURCES INC	13F	Company	0.74%	379,400	$12,095,000	—	31 Dec 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.61%	312,103	$9,949,000	—	31 Dec 2016	13F
HILLHOUSE INVESTMENT MANAGEMENT, LTD.	13F	Company	0.59%	304,256	$9,700,000	—	31 Dec 2016	13F
EverPoint Asset Management, LLC	13F	Company	0.56%	290,000	$9,245,000	—	31 Dec 2016	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.56%	288,365	$9,193,000	—	31 Dec 2016	13F
Chescapmanager LLC	13F	Company	0.53%	272,153	$8,676,000	—	31 Dec 2016	13F
Bank of New York Mellon Corp	13F	Company	0.39%	200,835	$6,403,000	—	31 Dec 2016	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.35%	182,365	$5,814,000	—	31 Dec 2016	13F
Point72 Asset Management, L.P.	13F	Company	0.33%	170,700	$5,442,000	—	31 Dec 2016	13F
State of New Jersey Common Pension Fund D	13F	Company	0.31%	160,459	$5,115,000	—	31 Dec 2016	13F
Opaleye Management Inc.	13F	Company	0.31%	158,200	$5,043,000	—	31 Dec 2016	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.28%	145,472	$4,638,000	—	31 Dec 2016	13F
BlackRock Investment Management, LLC	13F	Company	0.28%	144,619	$4,610,000	—	31 Dec 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.26%	135,501	$4,320,000	—	31 Dec 2016	13F
MORGAN STANLEY	13F	Company	0.24%	122,521	$3,906,000	—	31 Dec 2016	13F
D. E. Shaw & Co., Inc.	13F	Company	0.23%	120,437	$3,840,000	—	31 Dec 2016	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.2%	105,300	$3,357,000	—	31 Dec 2016	13F
ROYCE & ASSOCIATES LP	13F	Company	0.2%	103,300	$3,293,000	—	31 Dec 2016	13F
JPMORGAN CHASE & CO	13F	Company	0.18%	90,976	$2,901,000	—	31 Dec 2016	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.17%	87,800	$2,799,000	—	31 Dec 2016	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.16%	82,761	$2,638,000	—	31 Dec 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.15%	78,707	$2,506,000	—	31 Dec 2016	13F
S.c.a. Candriam	13F	Individual	0.15%	75,000	$2,391,000	—	31 Dec 2016	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.14%	72,567	$2,313,000	—	31 Dec 2016	13F
TEACHERS ADVISORS, LLC	13F	Company	0.14%	69,563	$2,218,000	—	31 Dec 2016	13F
Swiss National Bank	13F	Company	0.12%	63,342	$2,019,000	—	31 Dec 2016	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	58,048	$1,851,000	—	31 Dec 2016	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.11%	57,235	$1,825,000	—	31 Dec 2016	13F
Old West Investment Management, LLC	13F	Company	0.1%	52,016	$1,658,000	—	31 Dec 2016	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.1%	49,517	$1,579,000	—	31 Dec 2016	13F
NJ State Employees Deferred Compensation Plan	13F	Company	0.1%	49,284	$1,571,000	—	31 Dec 2016	13F
CREDIT SUISSE AG/	13F	Company	0.09%	47,188	$1,503,000	—	31 Dec 2016	13F
Allianz Asset Management GmbH	13F	Company	0.09%	46,499	$1,482,000	—	31 Dec 2016	13F
Invesco Ltd.	13F	Company	0.08%	43,411	$1,384,000	—	31 Dec 2016	13F
RHUMBLINE ADVISERS	13F	Company	0.08%	40,824	$1,301,000	—	31 Dec 2016	13F
ProShare Advisors LLC	13F	Company	0.08%	40,760	$1,299,000	—	31 Dec 2016	13F

Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) as of Q1 2017

As of 31 Mar 2017, Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) was held by 90 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,113,403 shares. The largest 10 holders included Woodford Investment Management Ltd, BAUPOST GROUP LLC/MA, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, FIRST MANHATTAN CO, Cormorant Asset Management, LLC, STATE STREET CORP, NORGES BANK, and Rock Springs Capital Management LP. This page lists 90 institutional shareholders reporting positions in this security for the Q1 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 holders

Q1 2017 holders

Holder diff

-6

Investor	Q4 2016 Shares	Q1 2017 Shares	Share Diff	Share Chg %	Q4 2016 Value $	Q1 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.